Inhibition of tissue transglutaminase by inhibition of tissue transglutaminase sensitizes TRAIL-resistant lung cancer cells through upregulation of death receptor 5

被引：0
|
作者：
Frese, S. [1 ]
Frese-Schaper, M. [1 ]
Schardt, J. [1 ]
Sakai, T. [2 ]
Schmid, R. [1 ]
机构：
[1] Univ Bern, Inselspital, CH-3010 Bern, Switzerland
[2] Kyoto Prefectural Univ Med, Dept Mol Targeting Canc Prevent, Kyoto, Japan
来源：
BRITISH JOURNAL OF SURGERY | 2010年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：30 / 30
页数：1
相关论文
共 50 条
  • [21] Lytic peptide-mediated sensitization of TRAIL-resistant prostate cancer cells to death receptor agonists
    Barua, Sutapa
    Linton, Rebecca S.
    Gamboa, Jennifer
    Banerjee, Ipsita
    Yarmush, Martin L.
    Rege, Kaushal
    CANCER LETTERS, 2010, 293 (02) : 240 - 253
  • [22] The combination of TRAIL treatment and cancer cell selective expression of TRAIL-death receptor DR4 induces cell death in TRAIL-resistant cancer cells
    Choi, E
    Kim, Y
    Kim, K
    YONSEI MEDICAL JOURNAL, 2006, 47 (01) : 55 - 62
  • [23] Proteasome Inhibition Sensitizes Prostate Cancer Cells to TRAIL-Induced Cell Death In Vivo
    Christian, Perry A.
    Thorpe, Jeffery A.
    Schwarze, Steven R.
    FASEB JOURNAL, 2008, 22
  • [24] Histone Deacetylase Inhibition (HDAC) Sensitizes Pancreatic Cancer Cells to TRAIL Induced Cell Death
    Chugh, R.
    Dudeja, V.
    Alsaied, O.
    Banerjee, S.
    Sangwan, V.
    Saluja, A.
    Vickers, S. M.
    PANCREAS, 2013, 42 (08) : 1344 - 1344
  • [25] Inhibition of JAK-2 Sensitizes Pancreatic Cancer Cells to TRAIL Induced Cell Death
    Dudeja, V.
    Skube, S.
    Beyer, G.
    Banerjee, S.
    Sangwan, V.
    Mujumdar, N.
    Mackenzie, T. N.
    Dawra, R. K.
    Vickers, S. M.
    Saluja, A. K.
    PANCREAS, 2011, 40 (08) : 1320 - 1320
  • [26] Antitumor Effect of Periplocin in TRAIL-Resistant gastric cancer cells via upregulation of death receptor through activating ERK1/2-EGR1 pathway
    Zhao, Lian-Mei
    Li, Lei
    Huang, Ying
    Han, Lu-juan
    Li, Dan
    Huo, Bing-Jie
    Dai, Su-li
    Xu, Li-yan
    Zhan, Qimin
    Shan, Bao-En
    MOLECULAR CARCINOGENESIS, 2019, 58 (06) : 1033 - 1045
  • [27] Acid ceramidase inhibition sensitizes human colon cancer cells to oxaliplatin through downregulation of transglutaminase 2 and β1 integrin/FAK - mediated signalling
    Klobucar, Marko
    Grbcic, Petra
    Pavelic, Sandra Kraljevic
    Jonjic, Nives
    Visentin, Sarah
    Sedic, Mirela
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 503 (02) : 843 - 848
  • [28] Digitoxin sensitizes glioma cells to TRAIL-mediated apoptosis by upregulation of death receptor 5 and downregulation of survivin
    Lee, Dae-Hee
    Lee, Chang Sup
    Kim, Dong-Wook
    Ae, Jeh Eun
    Lee, Tae-Hwa
    ANTI-CANCER DRUGS, 2014, 25 (01) : 44 - 52
  • [29] IFN-β sensitizes TRAIL-induced apoptosis by upregulation of death receptor 5 in malignant glioma cells
    Yoshimura, Sodai
    Sano, Emiko
    Hanashima, Yuya
    Yamamuro, Shun
    Sumi, Koichiro
    Ueda, Takuya
    Nakayama, Tomohiro
    Hara, Hiroyuki
    Yoshino, Atsuo
    Katayama, Yoichi
    ONCOLOGY REPORTS, 2019, 42 (06) : 2635 - 2643
  • [30] Tissue transglutaminase induces the release of apoptosis inducing factor and results in apoptotic death of pancreatic cancer cells
    Jansina Y. Fok
    Kapil Mehta
    Apoptosis, 2007, 12 : 1455 - 1463
12345